Who
T. Danny Phillips
Director
Company insider
Files Form 4 as: Director, Caris Life Sciences.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 11 Sep 2025
- Last trade
- 14 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 14 Aug 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —13,192 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —13,192 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | $75K3,739 at $20.06 | filing |
| 26 Feb 2026filed 27 Feb 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | $75K3,739 at $20.06 | filing |
| 11 Sep 2025filed 12 Sep 2025 | CAI Caris Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 11 Sep 2025filed 12 Sep 2025 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | $244K100,000 at $2.44 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.